An investment in Voyageur Minerals’ provides a direct and rare opportunity for exposure to the highest value (product line) in the Industrial Barite market: Pharmaceutical Barium Contrast.

  • Large market and only one main competitor in North America.
  • ImagingX Pharmaceuticals Inc has begun formulation and is preparing to begin production of barium contrast products using foreign USP barium sulfate.
  • Revenue from barium contrast sales will commence before the Frances Creek project goes into production, providing cash flow for the project.
  • Aging population more health care required
  • Barite contrast easily permitted by Canada Health and FDA.
  • Easily marketed, online and direct to hospitals and major radiology centers, market largely dependent on price.
  • The API (active pharmaceutical ingredient) is barite and is the largest and main ingredient.
  • Barium contrast media are used to improve pictures of the inside of the body produced by x-rays, computed tomography (CT), magnetic resonance (MR) imaging, and ultrasound.
  • Barium contrast materials allow the radiologist to distinguish normal from abnormal conditions.
  • Voyageur estimates a three month time line to produce one years supply of barite from its Frances Creek Barite deposit, for the barium contrast formulation.
  • ImagingX will begin development of iodine contrast products after cash flow commences to provide a full suite of products for the  contrast market.
  • Owning barite supply = vast competitive advantages

For further information, please contact us.